# Take Solutions (NSE: TAKE) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/TAKE · Pivot · prices to 22 Oct 2026

Take Solutions (NSE: TAKE) closed at ₹11.31 on 22 Oct 2026, down 0.53% on the day. With a market capitalisation of ₹167 Cr, it ranks 2373rd by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Biotechnology.

At its last close the stock traded at 39× trailing earnings, against a return on equity of 35.0% in FY26. Over the past year the share price has fallen 36.4%. Its 52-week range is ₹10.81 (22 Oct 2026) to ₹50.14 (20 Apr 2026); the last close is 77.4% below the high. In Q4 FY26, the quarter ended 31 Mar 2026, revenue was ₹54 Cr and net profit ₹4 Cr, on a consolidated basis. Promoters held 0.00% of the company as of 30 Jun 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Last close | ₹11.31 |
| Market cap | ₹167 Cr |
| P/E (trailing) | 39 |
| ROE | 35.0% (FY26) |
| ROCE | 15.4% (FY26) |
| Debt to equity | 0 |
| 52-week high | ₹50.14 (20 Apr 2026) |
| 52-week low | ₹10.81 (22 Oct 2026) |
| 1-year return | −36.4% |

## Quarterly results (₹ crore, consolidated)

| Quarter | Revenue | Revenue YoY | Net profit | Net profit YoY | EPS (₹) |
| --- | --- | --- | --- | --- | --- |
| Q4 FY26 | ₹54 Cr | — | ₹4 Cr | — | ₹0.29 |
| Q3 FY26 | — | — | ₹1 Cr | −97.7% | ₹0.07 |
| Q2 FY26 | — | — | ₹6 Cr | — | ₹0.43 |
| Q1 FY26 | — | — | −₹1 Cr | — | −₹0.06 |
| Q4 FY25 | — | — | −₹5 Cr | — | −₹0.33 |
| Q3 FY25 | — | — | ₹48 Cr | — | ₹3.26 |
| Q2 FY25 | — | — | −₹2 Cr | — | −₹0.11 |
| Q1 FY25 | — | — | −₹4 Cr | — | −₹0.26 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹0 Cr | ₹37 Cr |
| FY24 | ₹66 Cr | −₹120 Cr |
| FY23 | ₹189 Cr | −₹100 Cr |
| FY22 | ₹655 Cr | −₹782 Cr |
| FY21 | ₹774 Cr | −₹450 Cr |
| FY20 | ₹2,213 Cr | −₹11 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 0.00%
- Foreign institutions: 0.21%
- Non-institutions: 99.79%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Brooks Laboratories](https://app.pivotnow.in/stock/BROOKS) | ₹60.49 | ₹178 Cr | 7.2 | — |
| [Bal Pharma](https://app.pivotnow.in/stock/BALPHARMA) | ₹109.58 | ₹174 Cr | 27.7 | — |
| [Vaidya Sane Ayu](https://app.pivotnow.in/stock/MADHAVBAUG) | ₹161.10 | ₹169 Cr | — | — |
| [Medico Remedies](https://app.pivotnow.in/stock/MEDICO) | ₹20.40 | ₹169 Cr | 12.9 | — |
| [Panchsheel Org](https://app.pivotnow.in/stock/PANCHSHEEL) | — | ₹159 Cr | — | — |
| [Natural Capsules](https://app.pivotnow.in/stock/NATCAPSUQ) | ₹150.00 | ₹156 Cr | — | — |

## Questions and answers

### What is the share price of Take Solutions today?

Take Solutions (NSE: TAKE) last closed at ₹11.31 on 22 Oct 2026. Its 52-week high is ₹50.14 and its 52-week low is ₹10.81.

### What is the market cap of Take Solutions?

Take Solutions' market capitalisation is ₹167 Cr (₹167 Cr) at the 22 Oct 2026 close, ranking 2373rd among the NSE companies Pivot tracks.

### What is the P/E ratio of Take Solutions?

Take Solutions trades at a trailing P/E of 39. The median P/E of the 3 closest Pharma & Healthcare peers by market cap is 12.9.

### What is the ROE and ROCE of Take Solutions?

Return on equity was 35.0% in FY26 and return on capital employed was 15.4% in FY26 (consolidated figures).

### Is Take Solutions a debt-free company?

Take Solutions is close to debt-free: its debt-to-equity ratio was 0 in FY26.

### What were Take Solutions' latest quarterly results?

For Q4 FY26 (quarter ended 31 Mar 2026), Take Solutions reported revenue of ₹54 Cr and net profit of ₹4 Cr.

### How has Take Solutions stock performed over the last year?

Take Solutions' share price has fallen 36.4% over the past year, −45.2% over three months and −31.4% over one month, to the 22 Oct 2026 close.

### What is the shareholding pattern of Take Solutions?

As of 30 Jun 2026: promoters 0.00%, foreign institutions 0.21%, non-institutions 99.79%.

### Who are Take Solutions' competitors?

The listed Pharma & Healthcare companies closest to Take Solutions by market cap are Brooks Laboratories, Bal Pharma, Vaidya Sane Ayu, Medico Remedies, Panchsheel Org and Natural Capsules.

### Is Take Solutions a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Take Solutions' price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on TAKE against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.